Search Tag: Cancer
Screening-could-prevent-12-000-lung-cancer-deaths-a-year-in-the-u-s
2013 05 Mar
Screening for lung cancer with low-dose computed tomography (LDCT) in current and former smokers eligible for screening could avert approximately 12,000 lung cancer deaths each year in the United States, concludes a new analysis published online in CANCER, a peer-reviewed journal of the American Cancer Society. By providing a national estimate of...Read more
Scientists-eradicate-lung-tumors-in-a-pre-clinical-mouse-model
2013 09 Mar
Scientists at the Vall d´Hebron Institute of Oncology (VHIO) in Barcelona, Spain, report that they have eradicated lung tumours in a pre-clinical mouse model. Previous studies had already shown that Myc was a key protein in tumour development and had established how to inhibit Myc through gene therapy. This protein is involved in the development...Read more
New-abbott-test-helps-doctors-detect-the-presence-of-two-important-health-issues
2013 28 Mar
Abbot today announced that the ARCHITECT AFP test, which may help doctors detect serious birth defects and the progression of testicular cancer, received U.S. Food and Drug Administration (FDA) approval. Biomarkers, such as alpha-fetoprotein (AFP), are substances in the body that physicians can measure to identify the progress of diseases or conditions...Read more
Advances-in-molecular-testing-offer-new-hope-for-lung-cancer-patients
2013 04 Apr
The emergence of molecular diagnostic testing in lung cancer offers new hope for patients battling the number one cancer killer in the United States and abroad. Now, for the first time after a decade of biomarker testing in lung cancer, a uniform approach for testing for the EGFR mutation and ALK rearrangement along with the availability of targeted...Read more
Navidea-lymphoseek-r-gains-fda-approval
2013 16 Apr
Navidea Biopharmaceuticals, a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, has announced U.S. Food and Drug Administration (FDA) approval of Lymphoseek® (technetium Tc 99m tilmanocept) Injection, which is indicated for use in lymphatic mapping procedures to assist in the localisation of lymph nodes draining a primary...Read more
Breast-cancer-screening-time-for-a-new-paradigm
2013 18 Apr
Mammography, the gold standard of breast cancer screening, reduces breast cancer mortality, but has important limitations. Critics point to reduced sensitivity for women with dense breasts, a high rate of false positives leading to excessive biopsies, and concerns about long-term effects of repeated radiation. The authors of a review published...Read more
New-imaging-agent-enables-better-cancer-detection-and-staging
2013 24 Apr
Researchers at the University of California, San Diego School of Medicine have shown that a new imaging dye is an effective agent in detecting and mapping cancers that have reached the lymph nodes. The radioactive dye, called Technetium Tc-99m tilmanocept, successfully identified cancerous lymph nodes and did a better job of marking cancers than the...Read more
Microwave-imaging-can-monitor-treatment
2013 13 May
Microwave imaging can be used to monitor how well treatment for breast cancer is working, finds new research published in BioMed Central’s open access journal Breast Cancer Research. Microwave tomography, a low cost and repeatable technique, was able to distinguish between breast cancer, benign growths, and normal tissue. Eight women with breast...Read more
New-usa-lung-cancer-screening-guidelines
2013 13 May
New guidelines from the American College of Chest Physicians (ACCP) recommend offering low-dose computed tomography (LDCT) scanning for lung cancer screening to people with a significant risk of lung cancer due to age and smoking history. The guidelines recommend offering LDCT scanning to individuals at high risk of developing lung cancer, as part...Read more
International-study-closes-in-on-cancer-risk-markers
2013 22 May
Cancer research has taken a huge leap forward with scientists now able to identify more than 80 genetic markers found to increase the risk of breast, ovarian and prostate cancer. The COGS international research initiative is believed to be the largest of its kind. Although the results have been widely reported, the cross-border efforts behind...Read more
Ct-scans-in-childhood-and-adolescence-do-increase-cancer-risk
2013 24 May
Young people who undergo CT scans are 24 percent more likely to develop cancer compared with those who do not, a study published on bmj.com suggests. However, the absolute excess for all cancers combined was low, at 9.38 for every 100,000 person years of follow-up. The increasing use of CT scans has brought concerns about possible cancer risks,...Read more
Screening-for-lung-cancer
2013 27 May
A recently published article in the New England Journal of Medicine describe the screening, diagnosis, and limited treatment results from the initial round of screening in the National Lung Cancer Screening Programme in the United States. Participants with at least 30 pack-years of smoking and asymptomatic were randomly assigned to undergo annual...Read more
Cancer-risk-from-radiation-exposure-from-ct-scans
2013 10 Jun
According to a study of seven U.S. healthcare systems, the use of computed tomography (CT) scans of the head, abdomen/pelvis, chest or spine, in children younger than age 14 more than doubled from 1996 to 2005, and this associated radiation is projected to potentially increase the risk of radiation-induced cancer in these children in the future, according...Read more
Minimal-dose-ct-beats-x-ray-in-detecting-recurrent-lung-cancer
2013 12 Jun
In a study presented at the 93rd American Association for Thoracic Surgery Annual Meeting, investigators from the University of Toronto departments of Thoracic Surgery and Diagnostic Radiology show that minimal dose computed tomography (MnDCT) of the thorax offers much greater sensitivity at detecting new or recurrent lung cancer, with equivalent amount...Read more
Breast-cancer-screening-in-the-uk-no-effect-on-mortality-statistics
2013 13 Jun
New analysis of breast cancer mortality data over almost 40 years concludes that breast cancer screening does not yet show an effect on mortality statistics. The research, published in the Journal of the Royal Society of Medicine, analysed mortality trends before and after the introduction of the UK's National Health Service Breast Screening Programme...Read more
Screening-for-lung-cancer-the-nelson-study
2013 15 Jul
A recently published article in JBR-BTR details the Dutch NELSON trial, which is the first randomised lung cancer screening trial in which pulmonary nodule management is based on volumetry. The NELSON study is an ongoing multicentre randomised controlled multi-detector low-dose computed tomography lung cancer screening trial. The primary object...Read more
Intelligent-knife-tells-surgeon-which-tissue-is-cancerous
2013 18 Jul
Image courtesy of Imperial College London Scientists have developed an “intelligent knife” that can tell surgeons immediately whether the tissue they are cutting is cancerous or not. In the first study to test the invention in the operating theatre, the “iKnife” diagnosed tissue samples from 91 patients with 100 per cent accuracy, instantly...Read more
Massive-study-closes-in-on-cancer-risk-markers
2013 04 Sep
Cancer research has taken a huge leap forward with scientists now able to identify more than 80 genetic markers found to increase the risk of breast, ovarian and prostate cancer. The COGS international research initiative is believed to be the largest of its kind. Although the results have been widely reported, the cross-border efforts behind this...Read more
Zealous-imaging-leading-to-unncessary-treatment-for-low-risk-thyroid-cancer
2013 06 Sep
New imaging techniques are fuelling an epidemic in diagnosis and treatment of thyroid cancers that are unlikely to ever progress to cause symptoms or death, warn experts writing in the British Medical Journal. New technologies such as ultrasound, CT and MRI scanning can detect thyroid nodules as small as 2mm. Many of these small nodules are papillary...Read more
Outdoor-air-pollution-classified-as-major-environmental-contributor-to-fatal-cancer-by-iarc
2013 24 Oct
The International Agency for Research on Cancer (IARC), the dedicated cancer agency of the World Health Organisation, has in a recent statement classified outdoor air pollution as carcinogenic to humans. The IARC Monographs Programme gathered the world’s foremost experts in order to review the latest 1000 scientific papers...Read more
Special-camera-renders-tumours-visible
2013 08 Nov
Recovery and survival rates in patients suffering from cancer are significantly improved if tumours are removed in their entirety, however it is often very challenging for surgeons to identify and remove tiny clusters of cancer cells. A new camera, which can be used during surgery, enables the visualisation of hidden tumours. Even the most experienced...Read more
Cancer-treatment-response-impacted-by-tumours-oxygen-levels
2013 08 Nov
According to a recent study conducted by scientists from the Manchester Cancer Research Centre and published in ‘Clinical Cancer Research’, cancer patients’ treatments could be tailored to their personal needs by using their tumour’s genetic make-up in order to evaluate whether additional drugs could benefit their radiotherapy programme. It...Read more
Rsna-2013-innovative-ge-healthcare-technology-advances-cancer-care
2013 06 Dec
In their sustained commitment to accelerating cancer innovation and assembling tools to fight the disease, GE Healthcare, a unit of General Electric Company, showcased the company’s broad portfolio of advanced cancer treatment solutions at the 2013 Radiological Society of North America annual meeting. GE’s technological innovations include Positron...Read more
Tumour-promoting-gene-discovered
2013 09 Dec
More than one per cent of all cancer patients carry a gene which drives the development of tumours, and it is the first time ever that researchers have identified the gene CUX1 to be widely linked to cancer development. According to the team of researchers, deactivating CUX1 activates a biological pathway that enhances tumour growth. Drugs inhibiting...Read more
Innovative-health-screening-technology-launched-by-surrey-team
2013 20 Dec
A University of Surrey research team has developed an innovative device that can differentiate between normal and unhealthy cells. The team, led by Michael Hughes, Professor of Biomedical Engineering, has developed a device that analyses the electrical properties of cells - with hopes that it will enable the early detection of oral cancer and...Read more
Spread-of-cancer-potentially-halted-by-sticky-balls
2014 08 Jan
Early research suggests that cancerous tumour cells can be destroyed with sticky balls which consequently, may prevent cancer from spreading to other parts of the body. Once a tumour begins to spread around other areas of the body, it has reached its most dangerous and deadly stage and now scientists at the US Cornell University have successfully...Read more
Study-night-work-chrono-chaos-for-body
2014 21 Jan
Doing the night shift throws the body "into chaos" and could cause long-term damage, warn researchers. Shift work has been linked to higher rates of type 2 diabetes, heart attacks and cancer as people get too little sleep at the wrong time. The human body has its own natural rhythm, also called body clock, which is tuned to sleep at night and...Read more
Varian-medical-systems-s-probeam-proton-therapy-system-fda-approved
2014 22 Jan
Varian Medical Systems of Palo Alto, California, the world's leading manufacturer of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery and brachytherapy, has received US FDA 510(k) clearance for its updated ProBeam proton therapy system. Varian's ProBeam system gives clinicians options...Read more
World-cancer-day-why-it-s-crucial-to-debunk-cancer-myths
2014 04 Feb
Cancer Myths: Why it’s Crucial to Debunk Them With one third of all cancer cases being potentially preventable, it’s very important to know the signs and symptoms of cancer 4th February 2014 is World Cancer Day, an opportunity for the Union for International Cancer Control (UICC) to raise one voice in improving general knowledge surrounding...Read more
Cocir-raises-awareness-of-industry-achievements-on-world-cancer-day-2014
2014 04 Feb
Today is World Cancer Day 2014 and COCIR, the non-profit trade association of the European Radiological, Electromedical and Healthcare IT Industry, wants to take this opportunity to raise awareness of what our sector is contributing to the fight against cancer by providing solutions for the prevention, early diagnosis and treatment of this devastating,...Read more